THE IN VITRO CYTOTOXICITY, GENOTOXICITY AND OXIDATIVE DAMAGE POTENTIAL OF THE ORAL DIPEPTIDYL PEPTIDASE-4 INHIBITOR, LINAGLIPTIN, ON CULTURED HUMAN MONONUCLEAR BLOOD CELLS

BACKGROUND: Linagliptin (LNG) is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor that ameliorates blood glucose control of patients with type 2 diabetes, without developing hypoglycemic risk and weight gain with a good clinical and biological tolerance profile. To the best of our knowledge, its...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Endocrinol (Buchar)
Hauptverfasser: Çadirci, K., Türkez, H., Özdemir, Ö.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Acta Endocrinologica Foundation 2019
Schlagworte:
General Endocrinology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535332/
https://ncbi.nlm.nih.gov/pubmed/31149054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2019.9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge